top of page
BPIQ Blog
Oct 26, 20212 min read
Biopharma Daily Stock Updates - 10/26/21
$XBI $124.01 -0.31% Covid Updates $PFE +0.9% & BNTX -0.9% FDA Advisory Committee Votes in Favor of Granting Emergency Use Authorization...
Oct 25, 20213 min read
Biopharma Daily Stock Updates - 10/25/21
$XBI $124.39 +0.17% Covid Updates $MRNA +7.1% Moderna Announces Positive Top Line Data from Phase 2/3 Study of COVID-19 Vaccine in...
Oct 24, 20211 min read
Biopharma Daily Stock Updates - 10/22/21
$XBI $124.18 +0.27% Covid Updates $MRNA U.S. CDC Advisory Committee on Immunization Practices Recommends Booster Vaccination with...
Oct 21, 20212 min read
Biopharma Daily Stock Updates - 10/21/21
$XBI $123.84 +0.47% Covid Updates $COCP +4.5% Cocrystal Pharma to Present Data from its Oral and Intranasal COVID-19 Therapeutics...
Oct 20, 20212 min read
Biopharma Daily Stock Updates - 10/20/21
$XBI $123.26 +0.34% Covid Updates $MRNA -0.2% Moderna Announces FDA Authorization of a Booster Dose of Moderna’s COVID-19 Vaccine in...
Oct 19, 20212 min read
Biopharma Daily Stock Updates - 10/19/21
$XBI $123.68 +1.0% Covid Updates $NVAX -3.4% Novavax Statement on Initial Com-COV2 Phase 2 Clinical Trial Results Presented at World...
Oct 18, 20213 min read
Biopharma Daily Stock Updates - 10/18/21
$XBI $122.47 -2.1% Covid Updates $BNTX +5.4% New Formulation of COMIRNATY® Receives Positive Opinion from CHMP. source $DVAX +1.2%...
Oct 15, 20212 min read
Biopharma Daily Stock Updates - 10/15/21
$XBI $125.08 -1.5% Covid Updates $PFE -0.5% Pfizer and BioNTech Submit Data to EMA for the Vaccination of Children 5 to <12 Years of Age...
Oct 14, 20212 min read
Biopharma Daily Stock Updates - 10/14/21
$XBI $127.10 +1.67% Covid Updates $MRNA +3.2% Moderna Announces FDA Advisory Committee Unanimously Votes in Support of Emergency Use...
Oct 13, 20213 min read
Biopharma Daily Stock Updates - 10/13/21
$XBI $125.01 +0.32% Pipeline Updates $SRNE +2.3% Sorrento Receives FDA Clearance to Proceed With Clinical Trial for Anti-TROP-2...
Oct 12, 20212 min read
Biopharma Daily Stock Updates - 10/12/21
$XBI $124.61 +0.44% Covid Updates $MRNA +2.0% Moderna Announces COVAX Exercises Option to Purchase 176.5 Million Additional Doses of...
Oct 11, 20212 min read
Biopharma Daily Stock Updates - 10/11/21
$XBI $124.07 +0.5% Covid Updates $AZN +0.3% AZD7442 reduced risk of developing severe COVID-19 or death in TACKLE Phase III outpatient...
Oct 10, 20211 min read
Biopharma Daily Stock Updates - 10/08/21
$XBI $123.44 Pipeline Updates $FBIO Fortress Biotech and Cyprium Therapeutics Announce Positive Clinical Data for CUTX-101, Copper...
Oct 7, 20213 min read
Biopharma Daily Stock Updates - 10/07/21
$XBI $123.91 +1.32 Covid Updates $VXRT -0.14% New Duke University-led Study Shows That Vaxart's Oral COVID-19 Vaccine Candidate Reduces...
Oct 6, 20212 min read
Biopharma Daily Stock Updates - 10/06/21
$XBI $122.29 -1.06% Covid Updates $ENTA +1.1% NEW PRECLINICAL DATA FOR EDP-235, ENANTA’S ORAL PROTEASE INHIBITOR SPECIFICALLY DESIGNED...
Oct 5, 20212 min read
Biopharma Daily Stock Updates - 10/05/21
$XBI $123.60 +0.31% Covid Updates $MRNA +1.9% Moderna Announces European Medicines Agency Authorizes Third Dose of COVID-19 Vaccine...
Oct 4, 20213 min read
Biopharma Daily Stock Updates - 10/04/21
$XBI $123.22 -2.3% Covid Updates $BNTX -2.3% Pfizer and BioNTech Receive CHMP Positive Opinion for COVID-19 Vaccine Booster in the...
Oct 2, 20212 min read
Biopharma Daily Stock Updates - 10/01/21
$XBI $126 +0.5% Pipeline Updates $MCRB +4% SERES THERAPEUTICS PRESENTS LATE-BREAKING DATA FROM SER-109 PHASE 3 ECOSPOR III STUDY IN...
Sep 30, 20212 min read
Biopharma Daily Stock Updates - 09/30/21
$XBI $125.71 +0.06% Covid Updates $TRVN +0.8% Trevena Announces Results of TRV027 Proof-of-Concept Study in COVID-19 Patients source...
Sep 29, 20213 min read
Biopharma Daily Stock Updates - 09/29/21
$XBI $125.63 -1.7% Covid Updates $VBIV -4.3% VBI Vaccines Announces New Preclinical Data and Initiation of VBI-2905 Clinical Study...
Jump start your biotech due diligence
Our platform helps you uncover your next biotech investment opportunity
bottom of page